At a Glance
| Detail | Enter | TrialView |
|---|---|---|
| Category | eDiscovery | eDiscovery |
| Total raised | $135M | $4.1M |
| Rounds tracked | 2 | 1 |
| Latest round | Series B, $100M · May 2026 | Growth, $4.1M · Nov 2025 |
| Last valuation | $1.2B | Not disclosed |
| Lead investors | Founders Fund, Sequoia Capital | Elkstone Ventures |
| Built for | In-house teams | Not disclosed |
| Headquarters | Brazil | Ireland |
Funding, Side by Side
Enter rounds
- May 2026Series B$100M
- Sep 2025Series A$35M
TrialView rounds
- Nov 2025Growth$4.1M
Our Take
We have not tested these two head to head yet. The numbers above come from public funding announcements. If you use either one, tell us what you found and it may become a Field Note.
Quick Answers
- Which has raised more, Enter or TrialView?
- Enter has raised $135M in disclosed funding, compared with $4.1M for TrialView.
- Do Enter and TrialView share investors?
- No. None of the investors we track have backed both companies.
- What is Enter best for?
- Enter is a Brazilian AI platform that runs high-volume litigation for corporate legal departments.
Source: Legal Tech Circle funding data, from public announcements. Updated November 10, 2026.